Dark

TNDM
Tandem Diabetes Care, Inc.
stock NASDAQ

At Close

Jul 11, 2025 3:59:56 PM EDT

15.60USD-3.525%(-0.57)1,535,053

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 10, 2025 8:00:30 AM EDT

15.95USD-1.361%(-0.22)0

After-hours

Jul 11, 2025 4:27:30 PM EDT

15.86USD+1.667%(+0.26)2,661

OverviewOptionsHistoricalExchangesShortsNews

Jan 19, 2022

10:02AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022 Benzinga

06:17AM EST Wells Fargo Upgrades Tandem Diabetes Care to Overweight, Announces $160 Price Target Benzinga

Nov 4, 2021

08:22AM EDT Raymond James Maintains Outperform on Tandem Diabetes Care, Raises Price Target to $138 Benzinga

08:19AM EDT The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO Benzinga

06:32AM EDT SVB Leerink Maintains Market Perform on Tandem Diabetes Care, Raises Price Target to $140 Benzinga

Nov 3, 2021

05:33PM EDT Tandem Diabetes Care: Q3 Earnings Insights Benzinga

04:17PM EDT Tandem Raises FY21 Sales Guidance From $670M-$685M To $685M-$695M vs $684.32M Est. Benzinga

04:15PM EDT Tandem Diabetes Care Q3 EPS $0.09 Beats $0.06 Estimate, Sales $179.60M Beat $171.41M Estimate Benzinga

09:10AM EDT Earnings Scheduled For November 3, 2021 Benzinga

Nov 2, 2021

11:28AM EDT Earnings Outlook For Tandem Diabetes Care Benzinga

Sep 24, 2021

04:45AM EDT SVB Leerink Maintains Market Perform on Tandem Diabetes Care, Raises Price Target to $135 Benzinga

Sep 9, 2021

08:17AM EDT The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization Benzinga

Sep 8, 2021

07:32AM EDT The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod Benzinga

Sep 7, 2021

11:34AM EDT Shares of medical device manufacturer Tandem Diabetes Care, Inc. (TNDM) are up 11 percent on Tuesday's trading on news of the company making its entry in the S&P MidCap 400, before markets open for trading on September 20. RTTNews

Sep 3, 2021

06:56PM EDT Match Group, Ceridian HCM and Brown & Brown Set to Join S&P 500; Others to Join PR Newswire

Aug 5, 2021

07:31AM EDT Raymond James Maintains Outperform on Tandem Diabetes Care, Raises Price Target to $120 Benzinga

06:59AM EDT SVB Leerink Maintains Market Perform on Tandem Diabetes Care, Raises Price Target to $123 Benzinga

Aug 4, 2021

04:33PM EDT Tandem Diabetes Care Sees FY21 Sales $670M-$685M vs $637.16M Est. Benzinga

04:32PM EDT Tandem Diabetes Care Q2 EPS $0.06 Beats $(0.08) Estimate, Sales $172.10M Beat $143.63M Estimate Benzinga

04:10AM EDT Earnings Scheduled For August 4, 2021 Benzinga

Jun 28, 2021

10:44AM EDT Tandem Diabetes Sunday Highlighted Presentations Showing Improvements With Control-IQ Technology Benzinga

Jun 4, 2021

02:06PM EDT Tandem Diabetes Care Announces Presentations Demonstrating 'Immediate And Sustained Real-World Improvements With Control-IQ Technology' Benzinga

May 25, 2021

10:02AM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 Benzinga

06:36AM EDT Barclays Initiates Coverage On Tandem Diabetes Care with Underweight Rating, Announces Price Target of $90 Benzinga

May 6, 2021

08:15AM EDT SVB Leerink Maintains Market Perform on Tandem Diabetes Care, Raises Price Target to $102 Benzinga

May 5, 2021

04:52PM EDT Tandem Diabetes Raises FY21 Sales Guidance From $600M-$615M To $625M-$640M vs $610.5M Est. Benzinga

04:51PM EDT Tandem Diabetes Care Q1 EPS $(0.08) Beats $(0.16) Estimate, Sales $141.04M Beat $121.96M Estimate Benzinga

07:43AM EDT The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues Benzinga

04:16AM EDT Earnings Scheduled For May 5, 2021 Benzinga

Apr 1, 2021

06:36AM EDT SVB Leerink Maintains Market Perform on Tandem Diabetes Care, Lowers Price Target to $95 Benzinga

Feb 25, 2021

10:18AM EST Tandem Diabetes Care, Inc. (TNDM) shares are gaining more than 12 percent on Thursday morning trade as the company reported a surge in the fourth-quarter earnings as revenue increased 67 percent from last year. RTTNews

08:08AM EST The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants Benzinga

Feb 24, 2021

05:19PM EST Recap: Tandem Diabetes Care Q4 Earnings Benzinga

04:35PM EST Tandem Diabetes Sees FY21 Sales $600M-$615M vs $563M Estimate Benzinga

04:35PM EST Tandem Diabetes Care Q4 EPS $0.22 Beats $0.12 Estimate, Sales $168.06M Beat $141.58M Estimate Benzinga

07:30AM EST The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO Benzinga

03:35AM EST Earnings Scheduled For February 24, 2021 Benzinga

Feb 23, 2021

10:28AM EST A Preview Of Tandem Diabetes Care's Earnings Benzinga

Dec 15, 2020

09:42AM EST Benzinga's Top Upgrades, Downgrades For December 15, 2020 Benzinga

Nov 23, 2020

09:05AM EST Tandem Diabetes Care Announces Health Canada Approval Of The t:slim X2 Insulin Pump With Control-IQ Advanced Hybrid Closed-Loop Technology Benzinga

Nov 6, 2020

10:36AM EST SVB Leerink Maintains Market Perform on Tandem Diabetes Care, Raises Price Target to $130 Benzinga

09:40AM EST Raymond James Maintains Outperform on Tandem Diabetes Care, Raises Price Target to $124 Benzinga

Nov 5, 2020

04:47PM EST Tandem Diabetes Care Raises FY20 Sales Guidance From $450M-$465M To $465M-$475M Vs. $462.16M Est. Benzinga

04:45PM EST Tandem Diabetes Care Q3 EPS $(0.15) Misses $(0.10) Estimate, Sales $123.60M Beat $115.15M Estimate Benzinga

07:54AM EST The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping Benzinga

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Oct 13, 2020

09:59AM EDT Tandem Diabetes Care Option Alert: Oct 23 $120 Calls Sweep (8) near the Ask: 121 @ $3.557 vs 547 OI; Earnings 11/5 After Close Ref=$121.75 Benzinga

Aug 28, 2020

08:31AM EDT SVB Leerink Maintains Market Perform on Tandem Diabetes Care, Raises Price Target to $120 Benzinga

Aug 27, 2020

08:39AM EDT Tandem Diabetes Care Announces NEJM Publication Of Pediatric Study Demonstrating Increased Time-In-Range Using The T:Slim X2 Insulin Pump With Control-IQ Technology Benzinga

Aug 20, 2020

09:51AM EDT Benzinga's Top Upgrades, Downgrades For August 20, 2020 Benzinga

06:11AM EDT Wells Fargo Initiates Coverage On Tandem Diabetes Care with Overweight Rating, Announces Price Target of $120 Benzinga

Jul 31, 2020

02:01PM EDT Tandem Diabetes Care shares are trading higher after the company reported better-than-expected Q2 sales results. UPDATE: Shares have since reversed. Benzinga

11:03AM EDT Raymond James Maintains Outperform on Tandem Diabetes Care, Raises Price Target to $116 Benzinga

05:06AM EDT SVB Leerink Maintains Market Perform on Tandem Diabetes Care, Raises Price Target to $115 Benzinga

Jul 30, 2020

04:26PM EDT Tandem Diabetes Reinstates FY20 Sales Guidance Of $450M-$465M Benzinga

04:26PM EDT Tandem Diabetes Care Q2 EPS $(0.45) Misses $(0.24) Estimate, Sales $109.24M Beat $87.15M Estimate Benzinga

04:06AM EDT Earnings Scheduled For July 30, 2020 Benzinga